CHU de Nantes
Nantes, 46208, France
NCT Number: NCT03099993
In France, Cerebral Palsy (CP) affects 1 in 450 births. It results from lesions of the brain, before, during, or shortly after birth. These non-progressive lesions cause muscle impairments, responsible for activity limitations. These muscle impairments include muscle stiffness, and muscle weakness. Children with Unilateral CP (UCP) have these impairments on only one side of the body. To compensate for activity limitations with their impaired arm, these children over-use their non-impaired arm. The objective of constraint-induced therapy (CIT) is to minimize this asymmetry which deteriorates mobility on the impaired side, by forcing the child to only use its impaired arm several hours a day during several weeks of therapy. It is known using clinical tests that this therapy improves the overall motor function of the impaired arm. However, the underlying mechanisms are yet unknown. An understanding of these mechanisms would suggest ways to maximize the effectiveness of this therapy, which requires a significant commitment from the child and its family. The investigaors propose in this project a quantitative and objective evaluation of the effect of CIT on the movements of the impaired arm of children with UCP. The investogators focus their analysis on muscle activation, to assess which aspect of muscle impairments is modified by CIT. To this end, the investigators will use sensors identical to those already used in clinics for the Quantified Gait Analysis of children with CP, recognized since 2006 by the Haute Autorité de Santé as providing key supplementary data in the evaluation of complex gait disorders. Results from this study will provide leads to optimize CIT. Some children could for example benefit from CIT paired with treatments to reduce muscle stiffness or to strengthen muscles
Looking for future studies?
Notify Me6 year–17 year
All sexes
Interventional
Not applicable
Nantes, 46208, France
Quantitative and objective evaluation of upper limb movements will take place in a motion analysis laboratory and will take place as follow:
Duration of the protocol is about 1h30, with less than 30seconds of effort, and a few minutes of performing simple upper limb movements.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Maximal forces of elbow pronosupination and flexion-extension will be measured with a portable dynamometer.
Time frame: 5 weeks
Muscle activation envelopes come from electromyographic signals of upper limb muscles.
Time frame: 5 weeks
Kinematics: angles, velocities, accelerations of the thorax, shoulder, elbow and wrist in the three anatomical plans (sagittal, frontal, transverse).
Nantes University Hospital
Other
Quantified Analysis of the Movements of the Upper Limb of Children With Hemiparesis Participating in the Stress Induced Therapy Program
Acronym: MouvsupTCIHemi
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04235088
Unilateral Cerebral Palsy
Zaragoza, Spain
View Trial DetailsNCT07525752
Brain Damage, Chronic, Brain Diseases
Giza, Cairo Governorate, Egypt
View Trial DetailsNCT05355883
Brain Damage, Chronic, Brain Diseases
Greenville, North Carolina, United States
View Trial DetailsNCT05777070
Unilateral Cerebral Palsy
Greenville, North Carolina, United States
View Trial Details